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Summary
The long bones of the developing skeleton, such as those of the limb, arise from the process of endochondral ossification, where cartilage
serves as the initial anlage element and is later replaced by bone. One of the earliest events of embryonic limb development is cellular
condensation, whereby pre-cartilage mesenchymal cells aggregate as a result of specific cell–cell interactions, a requisite step in the
chondrogenic pathway. In this review an extensive examination of historical and recent literature pertaining to limb development and
mesenchymal condensation has been undertaken. Topics reviewed include limb initiation and axial induction, mesenchymal condensation
and its regulation by various adhesion molecules, and regulation of chondrocyte differentiation and limb patterning. The complexity of limb
development is exemplified by the involvement of multiple growth factors and morphogens such as Wnts, transforming growth factor-beta
and fibroblast growth factors, as well as condensation events mediated by both cell-cell (neural cadherin and neural cell adhesion molecule)
and cell–matrix adhesion (fibronectin, proteoglycans and collagens), as well as numerous intracellular signaling pathways transduced by
integrins, mitogen activated protein kinases, protein kinase C, lipid metabolites and cyclic adenosine monophosphate. Furthermore,
information pertaining to limb patterning and the functional importance of Hox genes and various other signaling molecules such as radical
fringe, engrailed, Sox-9, and the Hedgehog family is reviewed. The exquisite three-dimensional structure of the vertebrate limb represents
the culmination of these highly orchestrated and strictly regulated events. Understanding the development of cartilage should provide
insights into mechanisms underlying the biology of both normal and pathologic (e.g. osteoarthritis) adult cartilage. © 2000 OsteoArthritis
Research Society International
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One of the earliest overt morphogenetic events of
embryonic development is cartilage formation. Chondro-
genesis, the first step in endochondral ossification, ulti-
mately gives rise to skeletal tissues, which afford structure,
motility and protection to the developing vertebrate animal.
Cartilage development involves a series of multifaceted
and strictly regulated events, encompassing condensation
of mesenchymal chondroprogenitor cells, differentiation
into chondrocytes, and the patterning of chondrifying
tissues into skeletal structures. For a comprehensive analy-
sis of the formation of the three-dimensional vertebrate
limb, this review summarizes the molecular events contrib-
uting to the above processes, specifically cell–cell and
cell–matrix interactions, extra- and intracellular signaling
pathways, and regulation of gene expression.
It is noteworthy that while the embryonic limb has served
as a classic model for the study of cartilage development,
the cartilage anlage is eventually replaced by invading
osteoblasts to form bone. Understanding how this ‘tran-
sient’ cartilage is formed and more importantly, the control
of its maturation program, should also shed light on the
development and maintenance of the ‘permanent’ articular
cartilage found within joints.Address correspondence to: Rocky S. Tuan, Ph.D., Orthopaedic
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and T32ES07282).309Endochondral ossification
The formation of skeletal elements is a highly organized,
complex process that begins with the migration of undiffer-
entiated mesenchymal cells to areas destined to become
bone. These cells undergo a ‘condensation’ step1–4 that is
the result of an increase in cell packing, i.e. an increase in
cells/unit area or volume, without an increase in cell pro-
liferation.5,6 This process forms the cartilaginous anlagen
of the future skeletal elements. It is at this point that the
position, shape and number of the future skeletal elements
are established. The undifferentiated mesenchymal cells
produce an extracellular matrix (ECM) rich in collagen type
I,7–9 hyaluronan,10 tenascin11–14 and fibronectin.7,15 The
formation of pre-cartilaginous condensations and the differ-
entiation of mesenchymal cells into chondrocytes marks a
change in the ECM composition. The chondrocytes begin
producing cartilage specific collagen type II,16–20 collagen
types IX20–22 and XI, Gla protein,23–25 the large chondroitin
sulfate rich proteoglycan, aggrecan,26–29 and link protein,30
while the expression of collagen type I is turned off.31 The
chondrocytes become encased in their ECM and acquire a
characteristic rounded morphology. After further differentia-
tion and hypertrophy, the chondrocytes express collagen
type X and decrease the expression of collagen type II. The
cartilage is then vascularized by the invasion of blood
vessels from the perichondrium. Osteoblasts are trans-
ported into the cartilage by the blood vessels and begin
replacing the cartilage with mineralized bone. This process
of chondrogenesis, hypertrophy and mineralization, fol-
lowed by bone formation, is termed endochondral ossifi-
cation.32 The skeletal components of the axis, pelvis,
and limbs form by endochondral ossification, while the
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intramembranous ossification, the direct conversion of
undifferentiated mesenchymal cells into bone.Embryonic limb as a classic experimental model
The body plan is established in the early embryo by
precise coordination of cell migration, proliferation and
differentiation. The embryonic limb possesses two signal-
ing centers, the apical ectodermal ridge (AER) and the
zone of polarizing activity (ZPA), which produce signals
responsible for directing the proximo–distal outgrowth and
anterior–posterior patterning of the limb skeletal elements,
respectively. The embryonic limb has served for years
as the model system for studying pattern formation and
chondrogenesis, and this review will summarize the current
knowledge of mesenchymal cell pre-cartilaginous conden-
sation using the developing embryonic limb as its model
system (see ref. 33 for a presentation of current techniques
used in studying limb mesenchymal chondrogenesis).Origin and characterization of
chondroprogenitor cells
The cells that contribute to the skeletal elements of the
embryonic limb are derived from the lateral plate meso-
derm. These cells migrate into the limb field and undergo a
phenomenon termed ‘pre-cartilaginous condensation’, first
described by Fell.1 These condensations are easily visual-
ized, using standard light or transmission electron
microscopy, and appear as closely packed mesenchymal
cells in the chondrogenic regions when compared to the
surrounding nonchondrogenic mesenchyme. Another
method of visualizing cellular condensations is by taking
advantage of a characteristic specific to condensing,
pre-cartilage mesenchymal cells. These cells bind the
lectin peanut (Arachis hypogaea) agglutinin (PNA) that
recognizes the glycosyl terminal of the disaccharide
Gal(1,3)GalNAc,39–40 thereby demarcating cellular con-
densations during the development of skeletal tissues.41
Evidence suggests that PNA binds to some cell-surface
component(s) of the condensing mesenchymal cells.36,42
After chondrogenic differentiation, these cells are no longer
able to bind PNA, further illustrating the utility of PNA
binding as a method for identifying pre-cartilaginous cells.
In addition to the blastema in the limb bud, PNA has been
used to visualize sclerotomal condensations, the vertebrae
precursors, in the developing somites of both chick and
human embryos.42–44
It has been shown that nonchondrogenic tissues can
be induced to produce endochondral bone,45 suggesting
that chondroprogenitor cells reside in non-chondrogenic
tissues. This hypothesis was confirmed by testing the
ability of fractionated embryonic calvaria46–50 and muscle
tissue51 to undergo chondrogenesis in vitro.47,51 The PNA-
binding fraction formed aggregates of round cells and
produced cartilage specific collagen type II and aggrecan.
These results were dependent on the initial plating
density, consistent with previous observations that only
high density micromass cultures, a condition that
favors chondrogenesis,52–54 permit the expression of a
cartilaginous phenotype by mesenchymal cells.Pre-cartilage condensation
The appearance of pre-cartilage condensations is one of
the earliest morphological events in skeletogenesis.1,2,4This is a transient stage of skeletogenesis that provides the
scaffold for the formation of the endochondral skeletal
elements. It is at this time that the shape, size, position and
number of skeletal elements are established. The impor-
tance of the cellular condensation phase for normal skeletal
development was underscored by the observation of
Gru¨neberg,55 who named the condensation phase the
‘membranous skeleton’ to emphasize it as a distinct and
important phase of normal skeletal development. Several
mutant genes have been described that alter skeletal
development and act during the condensation step, such
as brachypod (bpH), phocomelia (Pa), and congenital
hydrocephalus (ch) in the mouse and talpid3 in the chick
(see refs 41 and 56 for discussion and references).
Cellular condensations form as a result of altered mitotic
activity, failure of cells to move away from a center, or as
in the limb, aggregation of cells toward a center. This active
cell movement causes an increase in mesenchymal
cell-packing density, i.e. an increase in cells/unit area
or volume, without an increase in cell prolifer-
ation,2,4,5,31,57–60 possibly mediated by ECM-driven
locomotion. Cellular condensation is associated with an
increase in cell–cell contacts through cell–cell adhesion
molecules and gap junctions that facilitate intercellular
communication and the transfer of small molecules
between cells.61–66 Evidence supporting the importance of
cellular condensation in chondrogenesis has come from
both in vivo and in vitro observations. Many classic studies
have not only demonstrated the high cell density require-
ment for chondrogenesis to occur,54 but have also corre-
lated the extent of cell condensation with the level of
chondrogenesis,53,67 demonstrated the initiation of gap-
junction-mediated cell–cell communication in condensing
mesenchyme,65,66 and described characteristic limb
skeletal abnormalities in genetic mutants defective in
mesenchymal cell condensation (reviewed in refs 41 and
56).
As stated previously, the process of mesenchymal cell
condensation is crucial for chondrogenesis. This process is
directed by cell–cell and cell–matrix interactions as well as
secreted factors interacting with their cognate receptors.
Prior to condensation, mesenchymal cells present in the
limb secrete an ECM rich in hyaluronan and collagen type
I that prevents intimate cell–cell interaction. As conden-
sation begins, an increase in hyaluronidase activity is
observed with a decrease in hyaluronan in the ECM.
Hyaluronan is thought to facilitate cell movement and the
increase in hyaluronidase and subsequent decrease in
hyaluronan allows for close cell–cell interactions.68–70 The
establishment of cell–cell interactions is presumably
involved in triggering one or more signal transduction
pathways that initiates chondrogenic differentiation. Two
cell adhesion molecules implicated in this process are
neural cadherin (N-cadherin) and neural cell adhesion
molecule (N-CAM). Both of these molecules are expressed
in condensing mesenchyme, then disappear in differentiat-
ing cartilage,71,72 and later are detectable only in the
perichondrium. Perturbing the function(s) of N-cadherin73
or N-CAM74 causes reduction or alterations in chondro-
genesis both in vitro and in vivo, further supporting a
role for these cell adhesion molecules in mediating the
mesenchymal condensation step.
In addition to cell–cell interactions, cell–matrix inter-
actions also appear to play an important role in mesen-
chymal cell condensation. One ECM component implicated
in this process is fibronectin. Fibronectin expression is
increased in areas of cellular condensation7,15 and
invading osteoblasts.
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facilitate a matrix-driven translocation of mesenchymal
cells into cellular condensations and this process may
be mediated by the amino terminal heparin binding
domain.75,76 Recent studies in our laboratory have demon-
strated that fibronectin mRNA undergoes alternative
splicing during chondrogenesis.77–79 The isoform con-
taining exon EIIIA is present during condensation but
disappears once differentiation begins, suggesting that this
isoform switching is important for cytodifferentiation to
occur. Antibodies specific for the region encoded by exon
EIIIA of the fibronectin gene inhibited chondrogenesis of
limb micromass cultures in vitro, and when injected into
chick limb buds in vivo, caused moderate to severe skeletal
77,78malformations.Limb patterning
INFLUENCES FROM THE EPITHELIUM
The development of the vertebrate limb as a functional
three-dimensional structure is a complex process depen-
dent on the interaction of various proteins, including growth
factors such as fibroblast growth factors (FGFs)80–84
and transforming growth factors (TGFs),85–91 morphogens
such as the Wnt family of secreted glycoproteins,92–94
and transcription factors such as engrailed (En),95 sonic
hedgehog (Shh),96,97 radical fringe (r-Frg),98,99 and those
encoded by the homeobox (Hox) gene family, such as
msx-1 and msx-2.100–102 The limb develops along three
axes: proximodistal (shoulder/finger) defined by the
FGFs,80–84 dorsoventral (knuckles/palm) defined by the
interaction of Wnt-7A and the En-1 transcription factor
domains,94,103 and the anterioposterior (pinky/thumb) axis
which is largely dependent on Shh and the Hox
genes.100–102,104–112 Although the above mentioned fac-
tors may indeed act specifically to initiate or maintain the
indicated axes of the developing limbs, these axes are
unlikely to exist as true independent domains, as loss of
the above factors in turn will affect all limb axes. The limb
can truly be considered an integrated structure, whose
development consists of the cooperative integration of
three axes, extensive cross-talk between numerous signal
transduction pathways and reciprocal induction between
ectoderm and underlying mesoderm.LIMB INITIATION
Early investigation into growth factors responsible for
limb initiation uncovered the presence of FGF-8 in lateral
plate mesoderm,80,83 and beads soaked in FGF implanted
at ectopic sites in the flank of the developing chick embryo
have been shown to cause the growth of an additional
limb.80,83,113 Most recently it was shown that expression of
fgf-10 presages that of fgf-8 in intermediate mesoderm, and
that ablation of fgf-8 expression in the mesonephros at
wing level still allows limb growth.114 This recent evidence
indicates that fgf-10 may be involved in early limb induction,
possibly through interaction with fgf-8.84
Though early limb growth is initiated by meso-
derm,115,116 the overlying limb ectoderm subsequently
begins to play an important role in maintenance of the
developing limb bud.117 At the distal tip of the growing limb
structure, the ectoderm located at the junction of the future
dorsoventral boundary begins to undergo a thickening to
form an area of specialized epithelium known as the AER.The AER is both induced and maintained by members of
the FGF family,80,83,113 and positioned by expression of
r-Frg in the dorsal ectoderm98,99 (Fig. 1). As the limb grows
further outward, cells directly underneath the AER in a
region termed the progress zone (PZ) proliferate rapidly
and maintain characteristics of undifferentiated mesen-
chyme, while the more proximal mesenchymal cells begin
to condense and differentiate into limb structures, specifi-
cally the cartilage anlage which will later be replaced by
41PROXIMODISTAL AXIS
After the initial induction of the AER by the underlying
mesoderm,115,116 further limb bud development becomes
dependent on signals emanating from the AER.118 Ectopic
implantation of AER to initiated limb bud results in produc-
tion of a second proximodistal axis,119 while surgical
removal of the AER halts limb outgrowth and results in a
truncated bud.119–121 However, implantation of beads
soaked in FGFs can substitute for the AER and maintain
proximodistal growth122,123 indicating that FGF-2, -4 and -8
secreted from the AER may be responsible for maintaining
the PZ and subsequently limb outgrowth.80,83,122,124–126
Both the AER and underlying mesoderm express members
of the bone morphogenetic protein (BMP) family, bmp-2, -4,
-7, and may function in AER or PZ maintenance, or FGF
induction.91 Until recently, the expression of fgf-8 was
considered to be the initial AER marker.80,83 However, new
work indicates that wnt-3A expression presages fgf-8
expression in the AER, and inappropriate expression of the
wnt-3A gene can in fact induce AER-specific genes such as
fgf-4, -8 and bmp-2.127
Patterning of structures comprising the proximodistal
axis of the limb are possibly determined by time spent in
the PZ (i.e. mesenchyme under the influence of the AER for
longer will form more distal structures),119 or the regulation
of morphogens by the AER as the PZ passes areas,
thereby ‘fixing’ particular proximodistal structures.128 As
cells leave the PZ they are left in a positional fate along all
three axes.ANTERIOPOSTERIOR AXIS
The anterioposterior axis (pinky–thumb) is the best
developmentally understood of the three limb axes and is
mediated by a small region of cells in the posterior mesen-
chyme of the limb bud known as the ZPA.104,120,128,129
Surgical removal and reimplantation of the ZPA at more
anterior sites causes digit duplication.106–108 One candi-
date molecule that emerged as the putative polarizing
region morphogen is retinoic acid, which when introduced
into an anterior site can mimic the ZPA in anterior mesen-
chyme130 and cause digit duplication.131,132 However, it
has been shown that both retinoic acid from the meso-
derm106 and FGF-4 from the AER exert their anterio-
posterior effects via activation of Shh in the ZPA133 (Fig. 1).
Shh in turn regulates bmp-2, -4, -7 and possibly the
expression of gli-1, -3 (zinc-finger transcription factors) in a
gradient through the limb mesoderm.134–139
It is thought that this regulation of bmps gives rise to
anterioposterior structures possibly through hox gene
regulation.106,140 The hox genes each contain a highly
conserved 60 amino acid motif called the homeobox, a
helix-turn-helix DNA-binding domain. Hox genes are organ-
ized into four clusters in an order colinear with the anterio-
posterior axis of the developing limb such that the 3′ most
312 A. M. DeLise et al.: Cartilage development and patterninggenes are expressed in the most anterior areas (for a
review of Hox gene structure and function see ref. 141).
Hox genes are expressed throughout both the AER and the
PZ.101,110,142–146 and appear to respond to soluble signals
emanating from the ZPA and the AER such as Shh,97,112
and FGFs,81,82 and Indian hedgehog (Ihh), a member of
the hedgehog family and a regulator of cartilage differen-
tiation147 (see below). The hox genes are thought also to
be responsible for encoding individual portions of the
141,148,149proximodistal axis.DORSOVENTRAL AXIS
Concerning limb axial development, the least under-
stood and last to be examined of the three axes has been
the dorsoventral axis. As with AER formation, ectodermal
signals have been implicated in the dorsoventral patterning
of the limb. There are four genes known to be differentially
expressed along the dorsoventral axis: en-1, r-Fng, wnt-7a,
lmx-1 (a homeodomain protein expressed in response to
wnt-7a)94,95,133,150–152 (Fig. 1). Both lmx-1 and wnt-7a loss
of function mutations transform dorsal limb structures to
ventral fate,94 and conversely loss of function En-1 mutants
cause dorsalization similar to wnt-7a/lmx-1 overexpres-
sion.103,151,152 A model has been proposed postulating that
En-1 functions in the ventral ectoderm to inhibit expression
of Wnt-7a and therefore Lmx-1, giving rise to ventral
98,99,103,153,154Fig. 1. Expression profiles of patterning genes during chick embryonic limb development. (a) Stage 16, pre-limb bud. Wnt-7a and radical
fringe (R-fringe) are expressed in the dorsal ectoderm and engrailed1 (En1) and BMPs are expressed in the ventral ectoderm of the pre-limb
bud. En1 restricts expression of Wnt-7a and R-fringe to the dorsal ectoderm. Wnt-7a induces the expression of Lmx1 and therefore, Lmx1
is restricted to the dorsal mesenchyme (see schematic in box). Members of the fibroblast growth factor (FGF) family are expressed
throughout both dorsal and ventral ectoderm. (b) Stage 21, early limb bud. The apical ectodermal ridge (AER) is formed at the junction of
cells that are either expressing or not expressing R-fringe. (c) Stage 20. Fgf4 is expressed in the posterior ridge ectoderm and Fgf8 is
expressed throughout the entire ridge ectoderm. The arrows indicate a positive feedback loop between Fgf4 and sonic hedgehog (Shh) in
the posterior mesenchyme. Each is required for the maintenance of expression of the other. Shh has been demonstrated as the principal
protein responsible for establishing proper anterior–posterior patterning of the limb. Figure adapted from refs 153 and 154.structures.Chondrocyte differentiation and maturation
The chondrocytes in the center of the cartilaginous
templates are stimulated to proliferate and then proceedthrough stages of maturation and hypertrophy. In the region
of hypertrophy the chondrocytes are replaced by invading
osteoblasts and the tissue is replaced by bone and bone
marrow. This process radiates outward with the formation
of the growth plates at the distal ends of the long bones that
separate the epiphysis from the diaphysis. Two signaling
molecules, Ihh and parathyroid hormone-related peptide
(PTHrP) have been identified as regulators of the process
of chondrocyte maturation and hypertrophy.
Ihh is a member of the hedgehog family of structurally
conserved, secreted proteins that are known to provide key
signals in embryonic patterning in many organisms. In
Drosophila development, the segment polarity gene hedge-
hog (hh) regulates embryonic segmentation and anterior–
posterior patterning of the imaginal disks.155–157 In higher
vertebrates, there are at least three hedgehog genes: Shh,
desert hedgehog (Dhh) and Ihh. The products of the
hedgehog genes undergo autoproteolysis generating
amino- and carboxy-terminal domains, with the former
likely to be responsible for the short- and long-range
signaling activities of the hedgehog proteins.158,159 The
different hedgehog proteins act through the same signal
transduction pathway. In the Drosophila hedgehog signal
transduction pathway, there are two key genes involved:
patched (ptc), which encodes a transmembrane protein,
and cubitus interruptus (ci), which encodes a transcription
factor. The vertebrate homologues of these genes are
Patched (Ptc) and Gli, and as in Drosophila, both are
required for cellular response to hedgehog signaling.160
The expression of Ihh is detected in the endoderm of the
developing midgut and lung and in the cartilage of the
developing long bones.147 In the developing long bones,
Ihh is expressed in the transitional region from proliferating
hypertrophic pathway.
ossification.
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are expressed in the perichondrium, suggesting that
the effect of Ihh is mediated by the perichondrium. Over-
expression of Ihh in the forming cartilage of chick em-
bryonic wings resulted in broader and shorter cartilage
elements that lacked hypertrophic chondrocytes.147 PTHrP
was found to be upregulated following Ihh misexpression in
the periarticular regions.
PTHrP is a paracrine factor that is synthesized in
multiple tissues. It is structurally homologous to parathyroid
hormone (PTH) and both bind the same receptor (PTH/
PTHrP receptor). Much of what is known about PTHrP in
chondrogenesis comes from mouse knockout studies.
Mouse embryos deficient in PTHrP develop relatively
normally despite the wide tissue expression of this gene.
The detected morphological abnormalities are restricted to
the skeletal system. The PTHrP null mice die shortly after
birth and are characterized by a domed head, short
snout and mandible, protruding tongue, disproportionately
short extremities, and a narrow thoracic cage.161 These
abnormalities are the result of advanced differentiation and
mineralization of chondrocytes resulting in premature
endochondral ossification.161,162 The result of the PTHrP
knockout clearly demonstrates a role for this gene in the
differentiation and maturation of chondrocytes into
hypertrophic chondrocytes.
The PTH/PTHrP receptor is a member of a new G
protein-coupled family163,164 and acts through the cAMP/
protein kinase A (PKA) and the phospholipase C/protein
kinase C (PKC) signaling pathways when activated by its
ligands.165,166 The PTH/PTHrP receptor is expressed in
many tissues including pre-hypertrophic and hypertrophic
chondrocytes of endochondral bones.162,164,167 This opens
the possibility that the PTH/PTHrP receptor is the mediator
of the PTHrP signal in the feedback loop that regulates
chondrocyte differentiation. Homozygous null mice for the
PTH/PTHrP receptor demonstrated a phenotype similar to
the PTHrP knockout in that they also exhibited a domed
head, short snout and mandible, protruding tongue and
disproportionately short limbs.168 Alizarin red S staining
of these embryos revealed inappropriately accelerated
mineralization in bones formed by endochondral ossifi-
cation. In addition, the mouse embryonic cell line ATDC5,
which can be induced by insulin in vitro to undergo
endochondral ossification, exhibits a cytodifferentiation-
dependent expression of the PTH/PTHrP receptor. When
induced by insulin, confluent cultures of ATDC5 cells
undergo cellular condensation with subsequent differen-
tiation into cartilaginous nodules. Expression of PTH/
PTHrP receptor mRNA is detectable in these cells at the
early stages of chondrogenesis, prior to the induction of
aggrecan gene expression, and was not seen in the undif-
ferentiated cells. Levels of PTH/PTHrP receptor mRNA
drastically increased concomitantly with that of collagen
type II, a marker of differentiated chondrocytes, suggest-
ing that the expression of the PTH/PTHrP receptor is
associated with the onset of chondrogenesis.169
The phenotype of the Ihh knockout mice is directly
opposite to that of the PTHrP and PTH/PTHrP receptor
knockout mice,168 suggesting that these genes are
involved in a negative feedback loop that regulates the
differentiation and maturation of chondrocytes. The follow-
ing mechanistic model has been proposed for PTHrP and
Ihh in cartilage development: as proliferating chondrocytes
enter into hypertrophy, they express high levels of the
PTH/PTHrP receptor and begin to express Ihh until they
become fully hypertrophic. The Ihh signal acts on thePtc/Gli expressing cells in the perichondrium adjacent to
the pre-hypertrophic zone inducing the expression of
PTHrP. PTHrP then signals back to the PTH/PTHrP
receptor expressing chondrocytes and ultimately prevents
undifferentiated chondrocytes from proceeding into the
147Cell adhesion in mesenchymal cell
condensation
Cell adhesion is mediated by two major groups of
cell–cell adhesion molecules, Ca2+-independent and Ca2+-
dependent.170–178 The Ca2+-independent group is com-
posed of the large immunoglobulin supergene family of
membrane glycoproteins known as cell adhesion mol-
ecules (CAMs), and the Ca2+-dependent group consists
largely of a class of transmembrane glycoproteins called
cadherins. Two adhesion molecules, N-cadherin and
N-CAM, have been shown to have an important role during
the pre-cartilaginous condensation phase in endochondral
73,74N-CADHERIN
The cadherin superfamily has many members and can
be divided into six gene subfamilies based on structural
homology: classical cadherins type I (e.g. E-, N-, P-,
R-cadherin), classical cadherins type II (cadherin-6 to -12),
cadherins found in desmosomes (desmocollins, desmo-
gleins), cadherins with a very short cytoplasmic domain or
none (LI-, T-cadherin), protocadherins, and the more dis-
tantly related gene products including the Drosophila
fat tumor suppressor gene, the dachsous gene and the
ret-proto-oncogene.179
The classical cadherins are a group of Ca2+-dependent,
single transmembrane glycoproteins which mediate cell–
cell adhesion by homotypic protein–protein interactions
through their extracellular domain. Classical cadherins are
synthesized as precursor polypeptides and are then pro-
cessed into their mature form. The extracellular domain of
the mature protein consists of five tandem repeat domains
termed cadherin-repeats, each of which consists of
approximately 110 amino acids. The cadherin-repeats form
four Ca2+-binding domains and the N-terminal repeat
confers the cadherin specific adhesive property of the
molecule. Classical cadherins have a single transmem-
brane domain followed by a highly conserved cytoplasmic
domain responsible for binding to the actin cytoskeleton via
the catenin molecules180 (Fig. 2).
The cadherin family of molecules exhibit spatio-
temporally unique patterns of gene expression177 and
demonstrate homotypic binding through their extracellular
domain, suggesting that cadherins may function as morpho-
regulatory molecules during development. N-cadherin,
named for its initial identification in neural tissues, was
one of the first identified cadherins and its functional in-
volvement in cell–cell adhesion and development have
been extensively studied.181–188 N-cadherin plays a major
role in neural development but has also been shown to
be expressed in other mesodermal tissues, including
developing limb mesenchyme.
N-cadherin is expressed in the developing embryonic
limb bud in a manner suggestive of a role in cellular
condensation.73 Immunohistochemical localization of
N-cadherin in the embryonic chick limb reveals a sparsely
314 A. M. DeLise et al.: Cartilage development and patterningscattered expression pattern in the central core mesen-
chyme during the pre-cartilage stage (Hamburger–
Hamilton stages 17/18 to 22/23).189 Expression
dramatically increases in the condensing central core at
stage 24/25, and by stage 25/26 the condensed central
core region begins to lose N-cadherin expression while
cells along the periphery of the limb bud begin to express
N-cadherin. By stage 29/30, the mature cartilage is com-
pletely devoid of N-cadherin while the condensing, peri-
chondral cells surrounding the forming cartilage still exhibit
high levels of N-cadherin. As the limb bud continues to
develop, the cartilaginous core region continues to grow
appositionally and it is likely that the N-cadherin positive
cells along the periphery contribute to this growth.73
In micromass cultures in vitro, dissociated limb mesen-
chymal cells aggregate to form cellular condensations
which ultimately differentiate into cartilaginous nodules,
separated by fibroblasts and myocytes.54 N-cadherin pro-
tein is synthesized by the aggregating (condensing)
mesenchyme by 12 h after initiation of the culture, whereas
the cells outside the condensation centers display no
evident N-cadherin expression. Expression of N-cadherin
becomes more intense as a function of time, with maximal
expression at 18 h. As the cells in the center of the
condensations differentiate they lose their N-cadherin pro-
tein and the cells along the immediate periphery of the
forming nodules maintain N-cadherin expression. Thus, the
expression pattern of N-cadherin in vitro recapitulates that
in the developing limb in situ.73
N-cadherin expression is localized to the prechondro-
blastic cells of the limb bud and maximal expression is seen
during mesenchymal cell condensation, after which it is
down-regulated, suggesting that cellular condensation
is dependent on N-cadherin-mediated cell–cell inter-
actions.71,73 Evidence to support this theory comes
from studies designed to perturb N-cadherin function.
Oberlender and Tuan71 were able to demonstrate a signifi-
cant inhibition of cellular condensation and chondrogenesis
in vitro and in vivo using a function-blocking monoclonal
antibody, NCD-2, directed against N-cadherin.182 These
findings correlate well with previous findings that exo-
genous Ca2+ significantly stimulates chondrogenesis
in vitro when added prior to condensation but has little
effect when added after.53,67
In similar studies, addition of the transforming growth
factor- family member, BMP-2, to chick limb bud or theC3H10T1/2 murine multipotential cell line plated at high
density micromass cultures stimulated chondrogenesis on
the basis of Alcian blue staining, collagen type II and link
protein expression, and an increase in (35S) sulfate
incorporation.85,190–192 Further investigation revealed
that BMP-2 treatment of C3H10T1/2 cells stimulated
N-cadherin mRNA levels four-fold within 24 h and protein
levels eight-fold by day 5 in culture, while an N-cadherin
peptidomimic containing the His–Ala–Val sequence was
able to inhibit chondrogenesis in a dose-dependent
manner.193 To specifically examine the influence of altered
N-cadherin expression or activity on chondrogenesis,
C3H10T1/2 cells were stably transfected with N-cadherin
wild type or dominant negative N-terminal deletion con-
structs. Cells expressing the wild type N-cadherin at a
moderate level (two-fold) increased chondrogenesis,
whereas cells expressing a four-fold increase in N-cadherin
or the dominant negative construct had an initial, inhibitory
effect on BMP-2 stimulation of chondrogenesis.193
These data strongly support a functional and activity-
dependent role for N-cadherin in cellular condensation and
chondrogenesis.Fig. 2. Schematic of N-cadherin–catenin complex. N-cadherin is a Ca2+ dependent, single pass transmembrane protein which mediates
cell–cell adhesion by homotypic protein-protein interactions through its extracellular domain. The extracellular domain is composed of five
tandem repeats, termed cadherin repeats, which form four Ca2+ binding sites. The fifth cadherin repeat confers its homotypic specificity by
the HAV (histidine–alanine–valine) amino acid sequence. The cytoplasmic domain binds the actin cytoskeleton via interactions with the
catenin family of proteins. The cytoplasmic domain binds /-catenin (/-cat) directly which in turn binds -catenin (-cat). Subsequently,
-catenin binds the actin cytoskeleton directly or in conjunction with -actinin. Other proteins also bind the cytoplasmic domain of N-cadherin,
such as p120ctn and the nonreceptor protein tyrosine phosphatase 1B (PTP1B). Both of these proteins bind the cytoplasmic domain and
regulate cell adhesion.243,244,265,266N-CAM
The glycoprotein N-CAM is a member of the immuno-
globulin superfamily.194 N-CAM is composed of five
immunoglobulin-like domains, each consisting of about 100
amino acids folded into beta sheets usually linked by a
disulfide bond.195 There is only one N-CAM gene; however,
different forms of N-CAM can be generated through alter-
native splicing of its mRNA as well as varying degrees of
glycosylation (sialic acid).196–198 The major mRNA splicing
differences occur near the carboxy-terminal with some
forms displaying altered cytoplasmic domains or missing
the transmembrane domain. Homotypic binding of N-CAM
occurs near the amino terminal,199,200 and does not appear
to be affected by alternative splicing.
N-CAM expression in the developing limb follows that of
the previously described N-cadherin, however, the expres-
sion of N-cadherin mRNA occurs earlier than that of N-CAM
mRNA.72 N-CAM expression in vivo is observed in all limb
bud cells by stage 22.14 N-CAM expression increases and
is enriched in the condensing mesenchyme at stage 27. By
stage 30, the cells in the center of the condensations
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cartilage, although strong N-CAM expression is maintained
in the surrounding perichondrium.14,74,201 The in vitro
N-CAM expression pattern parallels that of the in vivo
expression. In micromass cultures in vitro, N-CAM is
expressed after 1.5 days in the aggregating, pre-cartilage
condensations, with a zone of moderately N-CAM express-
ing cells surrounding the condensations. By 4 days in
culture, the condensations have differentiated into
cartilaginous nodules and lose the expression of N-CAM
at their center but retain N-CAM expression at their
periphery.74
The functional role of N-CAM in cellular condensation
and chondrogenesis was determined by perturbation
studies in vitro using aggregation assays and micromass
cultures. Aggregation of dissociated stage 23 chick limb
bud cells was reduced when incubated with anti-N-CAM
antibodies in suspension culture and compared to cells
incubated with non-immune Fab fragments.74 In the pres-
ence of anti-N-CAM antibodies, both the number and size
of aggregates is reduced by 50–60%. Micromass cultures
of chick limb bud mesenchyme demonstrated a reduction in
both the area occupied by condensations and the degree of
cartilage differentiation when incubated with anti-N-CAM
antibodies compared to the control cultures incubated with
nonimmune Fab or anti-fibroblast Fab. The effect observed
was dose-dependent.14,74 Overexpression of N-CAM in
micromass cultures results in enhanced aggregation of
mesenchymal cells, forming large cell aggregates which
differentiated into cartilaginous nodules and were collagen
type II-positive.74
A naturally occurring genetic mutation, Talpid2, is an
autosomal recessive disorder which manifests multiple
skeletal disorders including poly- and syndactyly.202 The
limb buds exhibit abnormally large pre-cartilage conden-
sations and the mesenchymal cells were shown to have
greater adhesiveness than control cells.203 Micromass
cultures of Talpid2 limb bud cells revealed fused pre-
cartilage condensations and a much greater amount of
chondrogenesis compared to cultures from normal
embryos. In addition, anti-N-CAM antibodies reduced the
size of cellular condensations and the degree of chondro-
genesis in the Talpid2 cultures, suggesting that the
increased condensations and chondrogenesis observed in
the Talpid2 chicks are at least partially mediated by an
14increase in N-CAM expression.Cell matrix interactions during mesenchymal
condensation
During condensation, communication between neighbor-
ing cells via adhesion and ECM molecules is critical in
order to establish both temporal and spatial regulation of
chondrogenesis in the developing limb. The ECM not only
functions in adhesive roles during condensation, but also
serves as regulators of growth factors and morphogens,
through presentation of molecules to their cognate recep-
tors. As an example, presentation of TGF to its type
II receptor via the ECM proteins betaglycan and endo-
glien.204,205 Furthermore, ECM molecules function in the
transmission of signals from the surrounding environment
of the cell to the cytoskeleton, cytoplasm and nucleus
through intricate signal transduction pathways, or by propa-
gating inside out signals from within the cells to the peri-
cellular environment. The ECM is thus a versatile regulatorof chondrogenesis through various functions during
mesenchymal condensation and differentiation.ECM MOLECULES REGULATED DURING CHONDROGENESIS
In vivo, pre-cartilage condensations coincide with tran-
sient up-regulation of several ECM proteins including
collagen type I, fibronectin and various proteo-
glycans.7,15,206,207 During this time there is also controlled
enzymatic hydrolysis of hyaluronan, resulting in decreased
extracellular and intercellular space which allows more
intimate cell–cell contact during condensation.10,70 As mes-
enchymal cells begin to condense and differentiate into
rounded chondrocytes, ECM production switches rapidly
from collagen type I to collagen type IIa (an alternatively
spliced form of collagen type II), and there is an increase in
the production of sulfated proteoglycans such as tenascin
and the chondroitin-sulfate rich aggrecan.31,206,208 These
molecules will constitute the majority of the environment
surrounding mature chondrocytes in cartilage elements.52
Transition from collagen type I to collagen type IIa is also
paralleled by a switch from 1 to 3 integrin expression
patterns that are indicative of the onset of chondrogenesis
and may prompt cellular differentiation.209 It has been
shown recently that the aggrecan-rich chondrocyte peri-
cellular matrix is anchored to the cell surface via
hyaluronan receptors (CD44) which function to direct the
assembly of the chondrocyte pericellular matrix.210 Another
ECM component, fibronectin, appears to promote cell
attachment and spreading over substratum,211 an event
necessary for mesenchymal condensation, but may be
inhibitive for chondrocyte function itself.212,213 In older
high-density micromass cultures, fibronectin is lost from
the cell surface of differentiating chondrocytes.214,215 Inter-
estingly, tenascin, which is up-regulated during differen-
tiation, is thought to inhibit chondrocyte attachment to
fibronectin.11,216
Fibronectin is a dimeric glycoprotein present in plasma
and in the ECM of many tissues, and plays an important
role in cell–matrix and matrix–matrix interactions, cell
migration, differentiation and the maintenance of cell
morphology. The fibronectin monomer consists of a
linear arrangement of amino acid repeats known as type I
(∼45 AA), type II (∼60 AA) and type III (∼90 AA) repeats to
yield a polypeptide chain of approximately 250 kDa.
Fibronectin is usually found as a dimer joined in the
C-terminal end by a pair of disulfide bonds and binds many
cell types through its integrin and nonintegrin receptors.
Fibronectin is encoded by a single gene but undergoes
alternative splicing of its mRNA to give rise to many
isoforms. Regions EIIIA or EIIIB are spliced to be either
totally included or excluded; however, the V region can be
spliced in several regions.217–220
Expression of fibronectin in the chick limb bud has been
shown to be distributed throughout the intercellular space
of mesenchymal cells prior to condensation, accumulates
in condensations, and reaches its maximal level of expres-
sion just prior to overt chondrogenesis.7,15,221–223 As car-
tilage matrix accumulates, fibronectin seems to diminish,
but digestion of the limb with hyaluronidase reveals the
presence of fibronectin throughout the cartilage
matrix.221,223 Therefore, fibronectin is present throughout
chondrogenesis and remains in differentiated cartilage.
Most interestingly, the exact structure of fibronectin (i.e. the
isoform expressed) changes during the process of chon-
drogenesis. Mesenchymal fibronectin contains both the
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EIIIA exon spliced out (B+A−), and plasma fibronectin has
both the EIIIA and EIIIB exons spliced out (B−A−).77–79,224
Previous work in the laboratory using exon-specific anti-
bodies has shown that antibodies directed against exon
IIIA, an affinity-purified monoclonal antibody specific for the
region encoded by exon IIIA of the fibronectin gene,
decreases the number of chondrogenic nodules formed in
micromass cultures of chick limb mesenchyme.78 The
effect seen was dose-dependent and time-dependent.
Specifically, the addition of exon IIIA antibody to cultures at
earlier times, after plating, decreases the area of the
cultures that forms nodules. Application of the antibody
after cellular condensation, i.e. 48 h after plating, has no
effect on nodule formation. Injection of exon IIIA antibody
into stage 23/24 chick limb primordia in vivo disrupted
normal limb chondrogenesis resulting in moderate to
severe skeletal malformations.78 The spatial and temporal
expression pattern of fibronectin and its isoform switching
suggest that exon IIIA may play a role in cellular conden-
sation, and that the cartilage isoform of fibronectin (B+A−)
may have some role in the maintenance of mature carti-
lage. It has been suggested that these alternative forms of
fibronectin play a functional role in the conversion of
mesenchyme to chondroblasts,225 possibly through inter-
nal signaling through the 51 integrin fibronectin receptor
and its associated integrin linked kinase (ILK) (see below).SIGNAL TRANSDUCTION FROM THE ECM
There is extensive cross-talk between signaling path-
ways activated by growth factor receptors such as epider-
mal growth factor (EGF), platelet-derived growth factor
(PDGF), insulin receptor and integrins, particularly at the
level of Ras, phosphoinositol-3 kinase (PI-3K) and focal
adhesion kinase (FAK) (for reviews see refs 226–228).
Upon binding fibronectin, the 1 subunits of integrins have
the ability to promote the assembly of focal adhesions and
activate FAK through autotyrosine phosphorylation. Acti-
vated FAK may then interact with the src homology (SH2)
domains of Src or Fyn,229 activate PI-3K230 and eventually
culminate in the regulation of mitogen-activated protein
kinases (MAPK), extracellular signal related kinase (ERK),
and Jun N-terminal kinase (JNK).231,232
Though the above pathways undoubtedly exert multiple
effects on condensation and chondrogenesis through ECM
induced gene regulation, a more direct pathway between
integrin signaling is possible through regulation of the ILK.
In contrast to FAK, which is active in response to cell
adhesion, ILK serine/threonine kinase appears to be inhib-
ited in response to fibronectin attachment to the integrin
receptor.233 It has been shown that overexpression of ILK
stimulates fibronectin matrix assembly in epithelial cells
and reduces cellular E-cadherin levels.234 Furthermore, in
more recent work, overexpression of ILK in mammary
epithelial cells resulted in down-regulation of epithelial
cadherin (E-cadherin) and translocation of -catenin, a
cadherin-associated and Wnt signal transducing protein,
to the nucleus. In the nucleus β-catenin forms an active
transcription complex with the lymphoid enhancing factor
(LEF-1), a context-dependent Wnt inducible transcription
factor. This overexpression of ILK also induced upregu-
lation of LEF-1 protein levels and caused rapid cell detach-
ment from the ECM.235 Finally, it has been shown that ILK
can inhibit the activity of glycogen synthase kinase-3
(GSK-3), another key mediator of the Wnt signaling path-way, through a PI–3K dependent mechanism.236 Since
Wnts are postulated to be involved in chondrogenesis in
the developing limb because of their temporal and spatial
expression patterns,93,237 and their ability to inhibit chon-
drogenesis in vitro,238 the activity of ILK via fibronectin
matrix assembly is a plausible link between secreted
morphogens and the ECM.
Tyrosine phosphorylation of adherens junctions has
been shown to regulate adhesiveness through cadherins
and their associated catenins.239–242 Furthermore, ECM
proteins have recently been identified as regulators of
phosphorylation via phosphatases. Specifically, membrane-
associated intracellular tyrosine phosphatase, protein tyro-
sine phosphatase-1B (PTP1B) like phosphatase, which is
thought to regulate phosphorylation of the N-cadherin as-
sociated -catenin,243,244 has been shown to be regulated by
interaction with the proteoglycan neurocan, a member of
the aggrecan family of chondroitin-sulfate-rich proteo-
glycans.245,246 Upon interaction of neurocan with its
cell surface ligand, N-acetylgalactosaminylphospho-
transferase (GalNAcPTase), PTP1B activity is lost, resulting
in increased tyrosine phosphorylation of junctions and
decreased adhesiveness,247 an event which possibly
plays a role in chondrogenesis, particularly following
condensation.GAGS AND WNT REGULATION
The cartilage matrix consists of a large amount of highly
charged glycosaminoglycans (GAG) such as heparan-
sulfate, keratan-sulfate, chondroitin-sulfate and dermatan-
sulfate in the form of high molecular weight proteoglycans,
including hyaluronan. These function to retain water,
thereby maintaining distance between cells, and serving as
shock absorbers. Interestingly, proteoglycans and GAGs
also act as molecular tethers of soluble factors involved in
both condensation and differentiation of mesenchymal
chondroprogenitor cells. Recently it was determined that
the heparan-sulfate cell-surface proteoglycan Dally, orig-
inally identified as a regulator of decapentaplegic (Dpp)
signaling, may act as a co-receptor for Wg and potentiate
its signal during development.248,249 Dally would then be a
plausible candidate for coordinating input from BMPs and
Wnts during chondrogenesis. It has also been shown that
disruption of the ionic environment surrounding chondro-
genic mesenchymal cells with the cationic cross-linker,
poly-L-lysine (PL), stimulates chondrogenesis,53,250 as
does addition of heparan-sulfate, heparin, dermatan-
sulfate and dextran-sulfate to chick limb mesenchymal
micromass.53
PL is thought to exert its stimulatory effects by altering
GAG biosynthesis and distribution, cross-linking proteo-
glycans and cells, altering cell shape, or by affecting the
activity of agents which regulate chondrogenesis.250 Inter-
estingly, we have recently shown that addition of PL to
embryonic chick limb micromass not only stimulates
chondrogenesis but also seems to do so via regulation of
N-cadherin expression.250 Hence, there is a plausible link
between Wnt signaling via GAGs and N-cadherin modu-
lation during mesenchymal chondrogenesis. Although PL
does not exist as an in vivo molecule, the chondro-
enhancing effects seen on chick mesenchymal micromass
strongly suggests that there may be biological counterparts
to PL, such as highly charged and localized domains of
ECM molecules. In fact, the matrix of cartilage contains a
large number of cationic proteins, and similarly, numerous
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ECM of cartilage cells.251 A specific example is fibronectin
which contains within its N-terminus repeated, lysine-rich
heparin-binding domains252 and is an attractive candidate
for an endogenous PL-like molecule. In fact, it has been
shown that the N-terminal domain of fibronectin acts to
enhance limb mesenchymal chondensations in a matrix
translocation mechanism75 consistent with the action of
poly-L-Lysine in promoting chondrogenesis.53,250
As mentioned earlier, the Wnt (Drosophila Wg) gene
family is thought to be involved in chondrogenesis in the
developing limb in view of its temporal and spatial expres-
sion profiles,93,237 and the ability of some Wnts to inhibit
chondrogenesis in vitro.238 Recently, it has been shown
that the secreted Wg protein interacts noncovalently with
the cell surface and can bind heparan sulfate directly,
conferring possible ECM regulation on Wg activity.253–255
Since Wg/Wnt proteins are conserved, it is likely that
proteoglycans and PL may regulate Wnt activity during
chondrogenesis when sulfated proteoglycans increase
dramatically in the extracellular matrix. As further proof of a
relationship between heparin-like GAGs and Wnt signaling,
it has been shown recently that the Drosophila mutants
kiwi and sugarless, which have mutations in the UDP-
glucose dehydrogenase gene, an enzyme required for
256,257GAG biosynthesis, mimic the Wg phenotype.Signaling molecules involved in mesenchymal
condensation and chondrogenesis
While cell–cell adhesion plays an integral part in the
condensation stage of chondrogenesis, it has been shown
that a number of signaling molecules, such as growth
factors (TGFs, FGFs), and their downstream effectors
(SMADs, MAPKs) are responsible for initiation and main-
tenance of the chondrogenic activity within the developing
limb. Similarly, transcription factors such as Hox, En and
LEF-1 are also important for limb patterning, whereas
members of the Wnt family may be involved in limb
initiation and maintenance. The current understanding of
the action of these signaling molecules is summarized
below.WNTS IN CHONDROGENESIS
As stated earlier, cadherin-dependent adhesion and
function appear to be regulated in part via the cytoplasmic
associated proteins, -, -, -catenin, and the newly
identified p120ctn.179,242,243,245,247,258–266 Interestingly,
-catenin is known to exist in three subcellular pools:
membrane bound in association with adhesion mol-
ecules,179 a cytoplasmic pool where -catenin binds the
adenomatous polyposis coli (APC) tumor suppressor pro-
tein through an internal repeat with amino acid homology to
the catenin binding region of E-cadherin,267,268 and a
nuclear pool in association with LEF and T-cell factors
(LEF-1/TCF).269–272 Due to the apparent ‘promiscuity’ of
the -catenin molecule, and the plausible titration between
various pools in either a signaling or adhesive capacity, it is
possible that mesenchymal condensation may also be
dependent on the temporal and spatial availability of
-catenin, possibly through regulation via Wnt signaling.
Recently it was determined that the interaction of APC
with -catenin is regulated by GSK-3, a key mediator of
the Wnt (Drosophila wingless: Wg) signaling path-way.273,274 The Wnt family consists of at least 15 cysteine-
rich secreted glycoprotein members, involved in cell fate
determination, induction of neural tissue, kidney tissue and
muscle and mammary glands, and has been shown to
effect axis determination in early embryos.237,275,276 Wnt
signaling is mediated by interaction with its membrane
receptor (Drosophila frizzled: DFz2),277,278 and following
regulation of various intermediate effectors, functions to
inactivate GSK-3 serine/threonine kinase activity.279–281
In the absence of Wnt signal, GSK-3 phosphorylates APC,
causing increased -catenin binding to the GSK-3-APC
complex,274 and this binding is quickly followed by
N-terminal phosphorylation of -catenin282 via GSK-3.273
The subsequent phosphorylation of -catenin serves as a
tag which targets the molecule for degradation by the
ubiquitin/proteasome pathway283–285 (Fig. 3).
Both GSK-3 and the ubiquitin pathway involved in
degradation of -catenin are regulated by PKC
activity,281,284,286 and serine/threonine phosphorylation of
-catenin may be reversed by the protein phosphatase type
1 and 2 family of phosphatases.273 In the presence of Wnt
and an inactive GSK-3, -catenin accumulates in the
cytoplasm, presumably in a signaling capacity, and even-
tually translocates to the nucleus via binding to nucleo-
porins,287 where it interacts with LEF-1/TCFs in an active
transcription complex269–271,288,289 (Fig. 3). The pool of
-catenin available for Wnt signaling is considered to be of
a very low level, and -catenin nuclear signaling may also
be regulated by adhesion molecules which sequester
catenins.290
Interestingly, Wnts may not be the only regulators of
-catenin and LEF-1 activity. As mentioned earlier, over-
expression of ILK-1 is able to increase expression levels of
LEF-1 and concomitantly down-regulates E-cadherin in
epithelial cells.235 The increased levels of LEF-1 caused
translocation of -catenin to the nucleus and activation of
LEF-1 responsive promoters. Although Wnts have been
identified as the primary candidates in regulation of
-catenin, this recent evidence indicates that at least one,
and possibly more, pathways intersect with the -catenin-
LEF-1 complex regulation. Though LEF-1/TCF--catenin
has been shown to have a positive regulatory effect on
certain promoters when present together, it has not been
dismissed that -catenin and LEF-1 in complex may also
have inhibitory qualities. Recently it was determined that at
times when there are low levels of -catenin in the nucleus,
the cyclic AMP response element binding protein binding
protein (CBP), a factor known exclusively for its coacti-
vation properties, binds and acetylates TCF, causing
decreased affinity for -catenin and inhibition of transcrip-
tion from TCF responsive promoters.291 LEF-1 and TCF-1
have been identified in developing mouse limb bud mesen-
chymal cells and in tail pre-vertebrae,292 and are induced
by BMP-4 during murine tooth and hair development.293
Furthermore, the LEF-1--catenin complex has recently
been shown to bind the E-cadherin promoter.270
Wnt-1 in PC12 cells has been shown to increase cell
adhesion through -catenin–cadherin interaction294,295 and
has been found to cause skeletal abnormalities in develop-
ing mouse limb when ectopically expressed in transgenic
mice.296 Interestingly, some Wnts have been postulated to
exert antagonistic effects towards each other in regulation
of embryonic responses, possibly through influencing
adhesion. Specifically, Wnt-5A appears to block Xenopus
dorsalizing response to Wnt-1, causing decreased
Ca2+-dependent cell adhesion, an effect mimicked by
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However, in this report, Wnt-5A was unable to block
dorsalization induced by injection of dominant negative
GSK-3 or -catenin, indicating that antagonism may occur
before the Wnt pathway reaches GSK-3.
Various Wnts are found throughout the developing limb.
Wnt-3, -4, -6, and -7B are expressed uniformly throughout
the limb ectoderm, Wnt-5A is expressed throughout the
distal mesenchyme,93,237 and Wnt-7A, expressed in dorsal
ectoderm,237 appears to act as dorsalizing signal94,133,151
since mice lacking Wnt-7A develop ventralized paws.94
Both Wnt-7A and Wnt-1 have been shown to inhibit
chondrogenesis in chick limb bud micromass cultures, and
the inhibition by these Wnts occurs after induction of
adhesion molecules and aggregation at the late-blastema/
early-chondroblast stage apparently by inhibition of
chondroblast differentiation.238 Wnt-4 has been implicated
in mesenchymal condensation in kidney development,298
and Wnt-3A, which has been isolated in the AER,127,299
leads to induction of BMP-2.127 Though the conserved
nature of Wnt proteins implies that they act through similar
pathways, Wnt-7A was recently found to exert its dorso-
ventral influence through a pathway other than the
-catenin/LEF-1 complex, whereas Wnt-3A in the AER
appears to utilize -catenin and LEF-1 in signaling.127
Our recent findings provide further support for the
functional involvement of Wnt signaling in chondrogenesis.
In high density micromass cultures of chick embryonic limb
mesenchyme cells, expression of Wnt-3, -5A, and -7A is
observed, with Wnt-7A expression showing down-
regulation over the course of chondrogenesis (Woodward
and Tuan, unpublished data). In cultures of the murine
multipotent C3H10T1/2 mesenchymal cells, maintained as
high density micromass to enhance cell–cell interaction
and cellular condensation, Wnt-3 expression is up-
regulated in response to the chondro-enhancer BMP-2
while Wnt-7A message is down-regulated upon addition of
BMP-2 to cultures (Fischer and Tuan, unpublished data).Furthermore, lithium, a Wnt mimetic by virtue of its inhi-
bition of GSK-3, inhibits chondrogenesis in both em-
bryonic chick limb mesenchyme (Woodward and Tuan,
unpublished data) and in BMP-2-treated C3H10T1/2 micro-
mass cultures (Haas and Tuan, unpublished data; Fischer
and Tuan, unpublished data).Fig. 3. Wnt signaling pathway. Wnt signaling is mediated by its interaction with its membrane receptor frizzled (Frz). Upon Wnt ligand binding,
glycogen synthase kinase 3 (GSK-3) is inactivated by a series of kinases and -catenin (-cat) accumulates in the cytoplasm and
translocates into the nucleus where it interacts with Lef1/TCF transcription factors initiating gene transcription. In the absence of Wnt binding,
GSK-3) phosphorylates adenomatous polyposis coli tumor suppressor gene (APC) causing an increased binding of -catenin to the
APC–GSK-3 complex followed by phosphorylation of -catenin. This complex is quickly degraded by the ubiquitin/proteosome pathway.TGF SUPERFAMILY IN CHONDROGENESIS
A number of growth factors have long been known to
regulate the initiation and maintenance of the developing
limb.300,301 Earlier in this review the FGF family was
discussed in the context of limb initiation, maintenance of
limb outgrowth, and reciprocal induction between the AER
and the PZ of the limb bud. In addition to the FGF family,
members of the TGF superfamily of cell–cell signaling
molecules have also been implicated in chondrogenesis302
and cell fate specification during embryogenesis.81,303–311
The TGF family members contain a conserved C-terminal
domain with several cysteine residues and consists
of BMP-2–8, as well as TGFs, activins/inhibins and
Mu¨llerian inhibiting substance.312,313 Members of the TGF
family have been shown to be multifunctional regulators of
cell growth, differentiation, and apoptosis, and act on a
large number of different cell types including osteo-
blasts and chondroblasts as well as neural and epithelial
cells.301,312
Among the TGFs, BMP-2 and BMP-4 are the most
highly conserved. The BMP molecule exists as a 30–38
kDa dimer which undergoes cellular processing by cleav-
age of an inactivating N-terminal domain.87,314 Further
regulation of their biological activity occurs through presen-
tation of the growth factors to their receptors by ECM
proteins such as betaglycan and endoglien which, due to
their regulatory effects, are considered to be type III recep-
tors for TGFs.204,205,315 The other protein receptors for
the TGFs exist in two forms:316–318 the growth factor
Osteoarthritis and Cartilage Vol. 8 No. 5 319Fig. 4. TGF signaling pathway. TGF binds the type II receptor that subsequently recruits and transphosphorylates the cytoplasmic tail of
the type I receptor. The MAP kinase kinase kinase TGF activated kinase (TAK1) and its binding partner TAK1 binding protein (TAB1),
through the activity of NEMO-like kinase (NLK), negatively regulates the Wnt pathway by directly phosphorylating Lef1, thereby preventing
its binding to -catenin (-cat). TGF can activate p21RAS by directly activating the type I receptor. SMAD proteins are phosphorylated in
response to TGF receptor activation. These proteins form a complex (SMAD 1/5) and enter the nucleus to activate gene transcription. Other
SMADs (SMAD 6,7) act to antagonize the SMAD 1/5 complex.densities.initially binds the upstream type II (TII) single pass mem-
brane receptor which recruits and transphosphorylates the
cytoplasmic tail of one of two type I receptors (TIa and
TIb).319,320 The activated TI receptor then, by virtue of a
cytoplasmic serine/threonine kinase domain, mediates
signaling through various intracellular pathways (Fig. 4).
The SMAD family of signaling molecules, homologues
of Drosophila mothers against decapentaplegic
(MAD),321–323 are activated in response to TGF binding to
its receptor. Although it is known that some SMADs trans-
locate to the nucleus in singular or as hetero-dimers
following interaction with TGF receptors,324 it is yet
unclear whether all SMAD family members have specificity
for individual members of the TGF family, or whether the
growth factors utilize various members of the SMADs to
carry out various effects in different cell types.325 Few
genes are currently known to be direct targets of BMP and
TGF signaling through SMADs,326 although recently it
was reported that MAD2, upon TGF stimulation, binds to
the Mix.2 transcription factor promoter.327
The TGFs also appear to signal through the MAPK
pathway via the MAP kinase kinase kinase, TAK1 (TGF
activated kinase),328 and its binding partner, TAB1 (TAK1
binding protein).329 Recent evidence indicates that TAK-1,
through NEMO-like kinase (NLK), negatively regulates the
Wnt pathway via direct phosphorlyation of LEF-1 and
inhibition of the ability of LEF-1 to bind -catenin (Fig.
4).330,331 Finally, TGF has been shown to activate p21ras
in epithelial cells,332 possibly through direct interaction with
the type I TGF receptor,333 and cellular response to
BMP-4 in Xenopus necessitates ras, raf and AP-1 func-
tion.334 As mentioned earlier, BMP-2 and -4 have been
shown to induce and maintain the expression of several
Homeobox genes, including Msx-1 and -2,88,335,336 as well
as induce LEF-1.293 BMP-4 has been shown to mediate
axis formation in Xenopus via Mix.1,337 and molecules
up-regulated in response to TGF treatment of cells include
ECM molecules such as osteopontin, osteonectin,tenascin, decorin and collagen types I, III, VI, and X
(reviewed in ref. 319).
Pioneer studies performed by Urist45 first suggested that
factors endogenous to demineralized bone were able to
induce endochondral ossification, i.e. chondrogenesis and
osteogenesis. A series of ensuing biochemical and molecu-
lar studies identified numerous growth factors within
demineralized bone, including the BMPs.300,338–341 Subse-
quent studies showed that injection of partially purified
BMPs,342 recombinant human BMP-2a and BMP-4,343,344
and Drosophila Dpp, a homologue of BMP-2,345 resulted in
ectopic cartilage and/or bone formation. A number of in vitro
studies have shown the osteogenic and chondrogenic
effects of BMP-2 and TGF.346–355 Furthermore, addition
of BMP-2 to embryonic chick limb bud mesenchyme or
the multipotent mouse C3H10T1/2 mesenchymal cell
line plated at high density initiates and/or enhances
chondrogenesis,190,191,353,356 and increases expression of
N-cadherin protein and mRNA.190,191,356
Examination of the developing limb identified BMP-5
within condensations near the posterior tips of buds,357 and
mouse genetic mutants deficient for BMP-5 develop
defects during early skeletal formation at the time of
mesenchymal condensation.358 BMP-2 has been identified
in both condensing vertebrae86 and posterior limb bud
mesenchyme where it acts as an anterior/posterior polariz-
ing signal.82,85,90,91 BMPs have also been implicated in
inducing apoptosis in interdigital spaces while TGFs
induce chondrogenesis in developing digits.90 Both in vitro
and in vivo studies combine to strongly implicate important
signaling and morphoregulatory function for members of
the TGF superfamily in both skeletal formation and
chondrogenesis. Finally, Cyr61, a growth factor-inducible
heparin-binding protein, has been recently shown to have
expression profiles within mesenchymal cells undergoing
chondrogenesis, and has been shown to promote chondro-
genic differentiation in cultures plated at subthreshold cell
359
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The above factors are likely to act in conjunction with
other signaling molecules secreted from limb mesenchyme
or overlying limb ectoderm. During initial condensation of in
vitro cultured mouse and chick limb bud mesenchyme, it
was determined that there is a modest increase in the
intracellular cAMP levels.360,361 Furthermore, addition of
exogenous cAMP derivatives has been shown to enhance
cartilage differentiation in in vitro studies,54,362–366 possibly
via enhanced GAG synthesis.367 Since the cAMP signal
transduction system is primarily modulated by cAMP-
dependent protein kinases (PKA) (for a review see ref.
368), researchers began examining the involvement of
PKA in cAMP-induced chondrogenesis, and recent reports
have indeed identified PKA as a chondro-enhancer.369
Activated PKA leads to regulation of cAMP responsive
genes via cAMP response elements within promoters,
cAMP response element binding protein (CREB), and CBP,
a protein also known to be involved in LEF-1 regulation.291
Increasing evidence indicates that PKC is involved in the
modulation of chondrogenesis. Stuarosporine, a PKC
inhibitor, has been shown to enhance chondro-
genesis,370,371 while modulation of PKC via tetradecanoyl-
phorbol acetate (TPA) inhibits chondrogenesis,369,372 and
leads to a decrease in the phosphorylation of CREB.369
Interestingly, some reports suggest that certain isoforms of
PKC are required for chondrogenesis.373 It has been
shown that PKC’s positive contribution to chondrogenesis
may be due to inhibition of Erk-1 which in turn down-
regulates the expression of various adhesion proteins such
as N-cadherin, fibronectin, and the 51 integrin recep-
tor,374 therefore regulating cellular differentiation. As men-
tioned earlier, PKC also appears to be involved in the
regulation of Wnt signaling,281,284,286 and in this capacity
may regulate chondrogenesis. Due to the large number of
PKC isoforms present within any given cell (for a review
see ref. 375) it is possible that certain PKCs may contribute
to the chondrogenic pathway while others exert a negative
effect on chondrogenesis.Patterning of cartilage development
Sculpting of the developing limbs results from the spatial
and temporal cooperative interactions between factors
secreted from limb epithelium, Wnts, and Hox genes within
the limb mesenchyme. The fact that TGFs act in part to
regulate the response of Hox genes, Shh, and the ECM
either directly or indirectly, indicates the strong functional
link between extracellular signals and an internal genomic
response of the mesenchymal cells during cartilage devel-
opment. The following section reviews the Hox and homeo-
box genes and discusses the possibility that they may
represent one of the targets under ECM regulation.HOX AND HOMEOBOX GENES
In both mouse and human, genomic analysis has ident-
ified the presence of 38 genes organized in four different
chromosomal complexes (Hox a, b, c, d), arranged such
that all the genes in each cluster are oriented in the same 5′
to 3′ direction.101,141 Genes located at the 3′ end of the
cluster are expressed prior to those at the 5′ end, and
genes more 3′ generally extend more anteriorly in the
developing limb. Several Hox genes are expressed during
limb initiation within the limb bud. Expression of Hoxa-10,-11 and -13 initiates distally at the posterior margin of
the bud (near the ZPA), and subsequently expands such
that the final boundaries of the expression domains are
perpendicular to the proximodistal axis.149,376–378
The Hox d genes have been extensively studied in
mouse and chick and can be ectopically activated by the
combined influence of Shh97,112 and FGFs.81,82 It has been
determined in early wing bud that Hoxd-9 and 10 are
uniformly expressed throughout the mesenchyme, whereas
Hoxd-11, -12, and -13 are found more posteriorly.379
Furthermore, Hoxd-13 expression is located at the furthest
posterior boundary, whereas that of Hoxd-10, -11 and -12
extend more anterior into limb mesenchyme. As limb
growth progresses, the expression domains of Hoxd-9 and
-12 extend further, though Hoxd-13 is restricted to the most
distal cells of the bud.380 When digit differentiation begins,
Hoxd-13 is expressed perpendicular to its initial orien-
tation.149 These spatiotemporally unique expression pro-
files of the Hox d genes suggest that they are functionally
important in early events of limb patterning.
Both Hox-7 and Hox-8 (Msx-1 and Msx-2) are expressed
in both AER and the PZ,100,149,381–384 and are considered
the earliest mesenchymal markers of the developing limb.
Possible functions of these genes in the PZ include main-
tenance of an undifferentiated population of cells or activat-
ing apoptosis.385,386 Furthermore, the AER is required for
maintenance of the expression of both Hox-7 and Hox-8
within the undifferentiated mesenchyme of the PZ.387 Can-
didate factors contributing to Hox gene maintenance
include BMP-2 and -4, which have been found to be
co-expressed with Msx genes at numerous sites, and can
induce expression of Hox-7 and -8 in vitro.88,335,388 Inter-
estingly, Ihh misexpression disrupts cartilage differentiation
and results in the misexpression of hox genes,147 indicat-
ing that the Hh family of transcription factors influence Hox
gene expression along with, or as a consequence of, the
action of various growth factors.
Recent in vivo studies have proved to be quite revealing
regarding the function of hox genes. The construction of
null alleles of various Hoxa and Hoxd genes in mice has
been enlightening with regard to their role in development
of the vertebrate limb. For example, Hoxa-10, -11 and -13
knockouts led to upper, middle limb defects and digital
reductions, respectively.148,389–391 Also, loss of Hoxa-11
activity led to defects that suggested a relationship
between proximodistal and anterioposterior patterning.148
Complete loss of the HoxD locus resulted in ulnar dys-
plasia,392,393 while analysis of individual Hox d genes
showed progressive mutations of limb from upper (Hoxd-
10) to middle (Hoxd-11) to digital (Hoxd-12,
-13).143,148,394–400 The results indicate that Hox genes
largely regulate the growth rates of mesenchymal
condensations within their zone of influence, and further-
more can exert influence at numerous times of
development.394,401–405 Hox gene mutations also appear
to have synergistic effects, indicating coordinated gene
activity as well as unique functions.394,401–405
Inappropriate expression of Hox genes has also been
shown to result in aberrant limb formation. For example,
proximal misexpression of Hoxd-13 in mouse results in
truncation of the radius–ulna and tibia–fibula,392,393 while
misexpression of Hoxb-8 causes duplication of the ZPA and
digit duplication.109 Hoxd-11, normally expressed in the
primordia of the posterior three digits of chick limb, was
misexpressed in the primordia of the most anterior digit
using retroviral infection; a morphological transformation
of digit I into digit II was observed.406 Furthermore
Osteoarthritis and Cartilage Vol. 8 No. 5 321mis-expression of Hoxa-13 in chick limb resulted in trans-
formation of the cartilage primordia of the zeugopodia from
elongated condensations to short condensations similar to
the morphology seen only in wrist elements, and appeared
407to suppress cell death.
specifying the cells destined to become cartilage.SOX GENES
The Sox genes comprise a large group of develop-
mentally regulated genes encoding transcription factors
that have critical functions in many developmental pro-
cesses, including sex determination, neural induction, and
skeletogenesis.408 Sox genes belong to the HMG box
superfamily [Sry-type high mobility group (HMG) box] of
genes that encode transcription factors. Members of the
Sox subfamily have an amino acid similarity of >50% to the
HMG domain of SRY, the testis determining factor, which
contains a domain similar to the nonhistone chromosomal
proteins HMG-1 and HMG-2. Sox proteins bind to the
(A/T)(A/T)CAA(A/T)G concensus motif in the minor groove
of DNA and induce DNA bending.409 Binding to the minor
groove and the ability to bend DNA has led to the hypoth-
esis that Sox proteins may also function as architectural
building blocks promoting the assembly of biologically
active multiprotein complexes.410
One member of the Sox subfamily, Sox9, has been
demonstrated to have a role in skeletogenesis. In humans,
haploinsufficiency of SOX9 results in a disease known as
campomelic dysplasia (CD) and XY sex reversal.411
Patients with CD have abnormalities in most cartilage
derived structures, resulting in bowing and angulation of
the long bones and craniofacial defects (reviewed in ref.
412). The embryonic expression pattern of Sox9 shows an
association of Sox9 mRNA expression with early events of
skeletal formation.413 During mouse development, Sox9
expression is seen in the mesenchyme of the head, the
sclerotome of the somites, and the condensations of
the limbs. The expression of Sox9 clearly preceded the
deposition of cartilage in these sites, suggesting that Sox9
is a determinant of chondrocyte differentiation rather than a
consequence.413 Sox9 is also expressed in nonskeletal
tissues such as the notochord, otic vesicle, neural tube,
brain and the developing gonads, suggesting that Sox9
may have other functions (reviewed in ref. 414).
During mouse embryonic development, Sox9 and col-
lagen type II (Col2a1), the major structural component and
marker of cartilage demonstrate very similar expression
patterns with the expression of Sox9 slightly preceding that
of Col2a1.413,415,416 Sox9 has been shown to bind to a
consensus sequence in the Col2a1 enhancer region
responsible for chondrocyte-specific expression417–420 and
mutations in this site abolishes Sox9 regulation.418,419
Recently, it has been shown that two other Sox proteins,
L-Sox5 and Sox6, form a complex with Sox9 to co-
operatively activate Col2a1 gene expression.421 Sox9 is
also able to activate Col2a1 reporter constructs containing
chondrocyte-specific enhancer sequences when Sox9
expression constructs were co-transfected into fibroblasts
and nonchondrogenic cell lines.418 In mouse Sox9−/− and
wild type chimeras, Sox9−/− cells were excluded from the
condensing mesenchyme; in addition, teratomas derived
from Sox9−/− embryonic stem cells did not form cartilage,
consistent with the assumption that Sox9 is required for the
cartilage phenotype.422
In summary, the importance of Sox9 in skeletal develop-
ment is clearly demonstrated by the identification of its rolein the human skeletal disorder, CD, while its embryonic
expression patterns implicates action during the very early
stages of chondrogenesis, most likely serving as a tran-
scription factor to induce the expression of the collagen
type II gene, perhaps by being an important architectural
component of a biologically active protein complex.OTHER PATTERNING MOLECULES
In addition to the Hox gene families, the ets gene
superfamily, which contains over 30 members, encodes a
class of evolutionarily conserved transcription factors that
bind a purine rich sequence through an 85 amino acid ETS
domain (reviewed in ref. 423). The chicken erg gene
(ck-erg) has been cloned.424 Expression patterns of ck-erg
and the closely related c-ets-1 gene are almost super-
imposable during early development, but distinct regions of
ck-erg expression appear during later stages of develop-
ment. These areas are the pre-cartilage condensations
and the cartilaginous blastemas preceding bone formation.
The functional role of these genes during endochondral
ossification has yet to be determined.
A new homeodomain-containing gene, cartilage
homeoprotein-1 (Cart-1), has been cloned from a rat
chondrosarcoma tumor and contains a paired-type homeo-
domain.425 Cart-1 is selectively expressed in pre-cartilage
mesenchymal condensations and in early chondrocytes. A
more detailed expression study of Cart-1 showed that this
gene is expressed in a subset of mesenchymal cells which
are either precursors of chondrogenic cells or have the
potential of becoming chondrogenic (e.g. mesonephros
and tendon).426 Expression of Cart-1 was often seen in
mesenchymal cells prior to the initiation of cellular conden-
sation, as well as in chondrogenic mesenchymal cell con-
densations. These observations suggest a role for Cart-1 in
426Conclusion
The transformation of loosely packed mesenchymal cells
into highly organized and patterned skeletal structures
requires the careful orchestration of cell–cell, cell–matrix,
and growth factor mediated signaling events which ulti-
mately result in the regulation of gene transcription and
function. ECM mediated mesenchymal cell condensation
facilitates the requisite cell–cell interactions which presage
changes in ECM composition and differentiation of mesen-
chymal cells into chondrocytes. Maturation and hypertro-
phy of chondrocytes is regulated by the two secreted
proteins Indian hedgehog and parathyroid hormone-related
peptide, which act through their cell surface receptors,
Patched and PTH/PTHrP receptor, respectively, to initiate
intracellular signal transduction pathways. In addition to its
structural characteristics, the ECM is extremely dynamic
and functions to transmit signals from the surrounding
environment of the cell to the cytoskeleton and subse-
quently activate signal transduction pathways, or propa-
gates inside-out signals from within the cells to the
pericellular environment. Furthermore, recent molecular
genetic advances have identified numerous genes, many
of which encode specific transcription factors and bioactive
growth factors, expressed within limb ectoderm and meso-
derm that are responsible for the patterning of the embry-
onic skeletal structures. The regulated cross-talk between
these genes acts spatially and temporally to guide the
322 A. M. DeLise et al.: Cartilage development and patterningpatterning of each of the skeletal elements. It is becoming
increasingly evident that the above signaling pathways are
not linear but intersect at various points and are respon-
sible for the strict control of the development of the embry-
onic skeletal structures. Thus, perturbations of the highly
orchestrated series of events in cartilage development,
either genetically or teratogenically, inevitably result in
skeletal birth defects.References
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AER Apical ectodermal ridge
APC Adenomatous polyposis coli
BMP Bone morphogenetic protein
CAM Cell adhesion molecule
CBP CREB binding protein
CD Campomelic dysplasia




EGF Epidermal growth factor
En Engrailed
FAK Focal adhesion kinase
FGF Fibroblast growth factor
GAG Glycosaminoglycan




ILK Integrin linked kinase
JNK Jun N-terminal kinase
LEF Lymphocyte enhancing factor
MAD Mothers against decapentaplegic
MAPK Mitogen activated protein kinase
N-CAM Neural cell adhesion molecule
NLK Nemo like kinase
PDGF Platelet derived growth factor
PI-3K Phospoinositol-3 kinase
PKA Protein kinase A




PTHrP Parathyroid hormone-related reptide




TAB-1 TAK binding protein
TAK-1 TGF- activated kinase
TCF T-cell factor
TGF Transforming growth factor
TPA Tetradecanoylphorbol acetate
ZPA Zone of polarizing activity
